UPDATED May 08, 2024
Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
2330 | NT$796.00 | 3.1% | 59.5% | NT$20.6t | NT$915.41 | PE24.1x | E16.1% | 1.8% | Semiconductors | ||
AZN | UK£122.64 | 0.9% | 2.9% | UK£190.1b | UK£133.20 | PE37.5x | E15.9% | 2.0% | Pharmaceuticals & Biotech | ||
NOVN | CHF90.54 | 1.9% | -2.2% | CHF184.7b | CHF98.47 | PE22.3x | E9.9% | 3.6% | Pharmaceuticals & Biotech | ||
QCOM | US$180.54 | 0.2% | 73.5% | US$201.5b | US$185.20 | PE23.8x | E8.9% | 1.8% | Semiconductors | ||
ROG | CHF222.30 | 3.8% | -21.3% | CHF179.4b | CHF279.39 | PE15.4x | E8.6% | 4.3% | Pharmaceuticals & Biotech | ||
SAF | €211.10 | 4.1% | 51.3% | €87.3b | €213.68 | PE25.3x | E6.9% | 1.0% | Capital Goods | ||
ZURN | CHF455.50 | 3.4% | 6.7% | CHF65.6b | CHF461.94 | PE16.6x | E8.9% | 5.6% | Insurance | ||
SLB | US$48.48 | 1.9% | 9.8% | US$68.4b | US$66.67 | PE16x | E15.2% | 2.3% | Energy | ||
LICI | ₹902.15 | -9.7% | 60.8% | ₹5.7t | ₹1,088.83 | PE15.8x | E8.2% | 0.9% | Insurance | ||
2454 | NT$1,095.00 | 9.5% | 63.9% | NT$1.7t | NT$1,214.84 | PE19x | E10.3% | 5.6% | Semiconductors | ||
300760 | CN¥303.63 | -0.3% | -0.1% | CN¥367.2b | CN¥395.41 | PE30.2x | E15.1% | 1.9% | Healthcare | ||
BBRI | Rp4,680.00 | -1.7% | -9.1% | Rp705.7t | Rp6,258.00 | PB2.4x | E9.6% | 6.8% | Banks | ||
BMRI | Rp6,275.00 | -0.8% | 23.0% | Rp585.7t | Rp7,525.29 | PB2.4x | E9.6% | 5.6% | Banks | ||
HAL | ₹3,846.65 | -2.5% | 154.9% | ₹2.6t | ₹3,229.58 | PE41.9x | E10.7% | 0.8% | Capital Goods | ||
EVO | kr1,235.00 | 2.4% | -7.8% | kr260.6b | kr1,486.96 | PE20.4x | E12.5% | 2.5% | Consumer Services | ||
300274 | CN¥106.59 | 3.1% | -4.1% | CN¥156.5b | CN¥130.74 | PE15.6x | E11.3% | 0.9% | Capital Goods | ||
KCHOL | ₺235.60 | 0.3% | 143.9% | ₺591.4b | ₺224.16 | PE8.3x | E26.5% | 3.4% | Capital Goods | ||
SOON | CHF266.80 | 2.7% | -5.9% | CHF15.9b | CHF270.88 | PE26.5x | E10.9% | 1.7% | Healthcare | ||
ALL | AU$39.16 | 0.4% | 1.6% | AU$24.8b | AU$47.49 | PE17.1x | E5.0% | 1.7% | Consumer Services | ||
LOGN | CHF76.68 | 2.8% | 33.7% | CHF11.8b | CHF75.61 | PE21.2x | E2.5% | 1.4% | Tech | ||
600845 | CN¥40.03 | -2.4% | -8.5% | CN¥81.2b | CN¥49.92 | PE36.4x | E21.3% | 2.5% | Software | ||
3231 | NT$112.00 | -2.2% | 135.8% | NT$321.5b | NT$152.34 | PE28x | E31.2% | 2.3% | Tech | ||
2648 | CN¥20.01 | 3.8% | 43.2% | CN¥67.3b | CN¥21.45 | PE13.2x | E19.5% | 2.0% | Materials | ||
300896 | CN¥218.76 | 1.8% | -39.6% | CN¥65.8b | CN¥315.86 | PE33.4x | E25.2% | 1.5% | Pharmaceuticals & Biotech |